n CME : Your SA Journal of CPD - More about : biological therapies in rheumatic disease

Volume 23, Issue 10
  • ISSN : 0256-2170



Extracted from text ... INGRID LOUW, MB ChB, MMed (Int Med) Rheumatologist in private practice Panorama and Cape Town Medi Clinic The early identification of rheumatoid arthritis (RA) is crucial to the success of treating this disease. There is a window of opportunity, thought to be within the first 3 months of diagnosis, in which disease-modifying drugs (DMARDs) should be started to ensure a good functional outcome for the patient.1 This is the most important factor in the treatment of rheumatoid arthritis. DMARD treatment success is well documented in clinical trials and post-marketing research, but erosions of joints still occur in spite of ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error